Two Sigma Advisers
AMED

Two Sigma Advisers’s Amedisys AMED Stock Holding History

Two Sigma Advisers’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-24,600
Closed -$2.42M – 2334
2025
Q2 		$2.42M Sell
24,600
-2,500
-9% -$237K 0.01% 1026
2025
Q1 		$2.51M Buy
27,100
+13,500
+99% +$1.24M 0.01% 1061
2024
Q4 		$1.23M Buy
13,600
+8,200
+152% +$753K ﹤0.01% 1361
2024
Q3 		$521K Buy
+5,400
New +$527K ﹤0.01% 1682
2023
Q3 		– Sell
-99,900
Closed -$9.13M – 2376
2023
Q2 		$9.13M Buy
99,900
+30,300
+44% +$2.49M 0.02% 522
2023
Q1 		$5.12M Buy
69,600
+16,600
+31% +$1.44M 0.01% 798
2022
Q4 		$4.43M Buy
53,000
+45,200
+579% +$4.08M 0.01% 835
2022
Q3 		$755K Sell
7,800
-13,000
-63% -$1.55M ﹤0.01% 1665
2022
Q2 		$2.19M Sell
20,800
-2,600
-11% -$332K 0.01% 1167
2022
Q1 		$4.03M Sell
23,400
-6,700
-22% -$1M 0.01% 905
2021
Q4 		$4.87M Sell
30,100
-17,100
-36% -$2.75M 0.01% 779
2021
Q3 		$7.04M Sell
47,200
-40,300
-46% -$8.38M 0.02% 634
2021
Q2 		$21.4M Buy
87,500
+10,600
+14% +$2.78M 0.06% 317
2021
Q1 		$20.4M Sell
76,900
-53,600
-41% -$15.1M 0.06% 357
2020
Q4 		$38.3M Sell
130,500
-47,200
-27% -$12.1M 0.1% 209
2020
Q3 		$42M Buy
177,700
+40,500
+30% +$9.21M 0.12% 172
2020
Q2 		$27.2M Buy
137,200
+11,800
+9% +$2.2M 0.08% 263
2020
Q1 		$23M Buy
125,400
+74,500
+146% +$13.3M 0.09% 262
2019
Q4 		$8.5M Sell
50,900
-13,818
-21% -$2.06M 0.02% 645
2019
Q3 		$8.48M Sell
64,718
-56,400
-47% -$7.34M 0.02% 597
2019
Q2 		$14.7M Sell
121,118
-119,000
-50% -$14.1M 0.04% 484
2019
Q1 		$29.6M Buy
240,118
+102,700
+75% +$12.9M 0.07% 313
2018
Q4 		$16.1M Buy
137,418
+35,900
+35% +$4.23M 0.04% 438
2018
Q3 		$12.7M Buy
101,518
+81,600
+410% +$9.01M 0.03% 514
2018
Q2 		$1.7M Sell
19,918
-8,100
-29% -$595K ﹤0.01% 1384
2018
Q1 		$1.69M Sell
28,018
-32,000
-53% -$1.82M ﹤0.01% 1323
2017
Q4 		$3.16M Buy
60,018
+18,000
+43% +$949K 0.01% 1041
2017
Q3 		$2.35M Sell
42,018
-2,400
-5% -$127K 0.01% 1118
2017
Q2 		$2.79M Sell
44,418
-6,000
-12% -$349K 0.01% 1037
2017
Q1 		$2.58M Sell
50,418
-6,400
-11% -$305K 0.01% 1136
2016
Q4 		$2.42M Sell
56,818
-21,500
-27% -$914K 0.01% 1079
2016
Q3 		$3.71M Sell
78,318
-13,300
-15% -$664K 0.02% 764
2016
Q2 		$4.63M Sell
91,618
-31,400
-26% -$1.58M 0.02% 572
2016
Q1 		$5.95M Sell
123,018
-16,300
-12% -$629K 0.03% 460
2015
Q4 		$5.48M Sell
139,318
-18,600
-12% -$744K 0.03% 422
2015
Q3 		$6.01M Buy
157,918
+5,100
+3% +$215K 0.04% 431
2015
Q2 		$6.07M Buy
152,818
+47,700
+45% +$1.49M 0.05% 420
2015
Q1 		$2.81M Sell
105,118
-7,200
-6% -$203K 0.02% 653
2014
Q4 		$3.3M Buy
112,318
+9,800
+10% +$242K 0.03% 625
2014
Q3 		$2.07M Buy
102,518
+64,400
+169% +$1.24M 0.02% 802
2014
Q2 		$638K Buy
38,118
+7,800
+26% +$111K 0.01% 1490
2014
Q1 		$451K Buy
30,318
+1,400
+5% +$21.5K ﹤0.01% 1633
2013
Q4 		$423K Sell
28,918
-1,900
-6% -$30.6K ﹤0.01% 1699
2013
Q3 		$531K Sell
30,818
-7,400
-19% -$110K 0.01% 1344
2013
Q2 		$444K Buy
+38,218
New +$438K 0.01% 1410

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Two Sigma Advisers's AMED Position: Q3 2025 in Review

Two Sigma Advisers sold out of Amedisys (AMED) in Q3 2025, closing a stake of 24,600 shares — an estimated $2.42M sold.

Two Sigma Advisers first reported a position in AMED in Q2 2013 and held it in 45 quarters. The position peaked at $42M in Q3 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Two Sigma Advisers reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Advisers sold 24,600 Amedisys shares in Q3 2025, an estimated $2.42M.
  • Two Sigma Advisers first reported a position in Amedisys in Q2 2013 and held it in 45 quarters.
  • Two Sigma Advisers's Amedisys position peaked at $42M in Q3 2020.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Two Sigma Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.